NeOnc Technologies Reports Positive Topline Phase 2a Results for Intranasal NEO100 in Recurrent IDH1-Mutant High-Grade Glioma

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/14/2026

1. NVDA
2. ORCL
3. USO
4. SPY
5. SRRK
6. DFTX
7. AZN
8. CGEM
9. BAC
10. LYNX

Go back to NeOnc Technologies Reports Positive Topline Phase 2a Results for Intranasal NEO100 in Recurrent IDH1-Mutant High-Grade Glioma
(NASDAQ: NTHI) Delayed: 3.78 +0.10 (2.72%)
Previous Close $3.68    52 Week High $ 
Open $3.82    52 Week Low $ 
Day High $4.00    P/E N/A 
Day Low $3.69    EPS $ 
Volume 290,506